Icon

HOVILPRI (NDA221154)- (EQ 100MG BASE)

PRITELIVIR MESYLATE AICURIS ANTI-INFECT
EQ 100MG BASE
No No
Expired Expired
None None
None No
HOVILPRI is a herpes simplex virus (HSV) helicase-primase inhibitor indicated in immunocompromised adults for the treatment of mucocutaneous lesions caused by herpes simplex virus (HSV) infection that is refractory (with or without documented resistance) to treatment with acyclovir, valacyclovir, or famciclovir.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 100MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.